A Curated Database of Rodent Uterotrophic Bioactivity

Background: Novel in vitro methods are being developed to identify chemicals that may interfere with estrogen receptor (ER) signaling, but the results are difficult to put into biological context because of reliance on reference chemicals established using results from other in vitro assays and because of the lack of high-quality in vivo reference data. The Organisation for Economic Co-operation and Development (OECD)-validated rodent uterotrophic bioassay is considered the “gold standard” for identifying potential ER agonists. Objectives: We performed a comprehensive literature review to identify and evaluate data from uterotrophic studies and to analyze study variability. Methods: We reviewed 670 articles with results from 2,615 uterotrophic bioassays using 235 unique chemicals. Study descriptors, such as species/strain, route of administration, dosing regimen, lowest effect level, and test outcome, were captured in a database of uterotrophic results. Studies were assessed for adherence to six criteria that were based on uterotrophic regulatory test guidelines. Studies meeting all six criteria (458 bioassays on 118 unique chemicals) were considered guideline-like (GL) and were subsequently analyzed. Results: The immature rat model was used for 76% of the GL studies. Active outcomes were more prevalent across rat models (74% active) than across mouse models (36% active). Of the 70 chemicals with at least two GL studies, 18 (26%) had discordant outcomes and were classified as both active and inactive. Many discordant results were attributable to differences in study design (e.g., injection vs. oral dosing). Conclusions: This uterotrophic database provides a valuable resource for understanding in vivo outcome variability and for evaluating the performance of in vitro assays that measure estrogenic activity. Citation: Kleinstreuer NC, Ceger PC, Allen DG, Strickland J, Chang X, Hamm JT, Casey WM. 2016. A curated database of rodent uterotrophic bioactivity. Environ Health Perspect 124:556–562; http://dx.doi.org/10.1289/ehp.1510183

[1]  M S Christian,et al.  Variability in the uterotrophic response assay (an in vivo estrogenic response assay) in untreated control and positive control (DES-DP, 2.5 microG/kg, bid) Wistar and Sprague-Dawley rats. , 1998, Drug and chemical toxicology.

[2]  Patience Browne,et al.  Screening Chemicals for Estrogen Receptor Bioactivity Using a Computational Model. , 2015, Environmental science & technology.

[3]  Ruili Huang,et al.  Predictive endocrine testing in the 21st century using in vitro assays of estrogen receptor signaling responses. , 2014, Environmental science & technology.

[4]  S. Mirkin,et al.  Selective estrogen receptor modulators (SERMs): a review of clinical data. , 2015, Maturitas.

[5]  Ruili Huang,et al.  Integrated Model of Chemical Perturbations of a Biological Pathway Using 18 In Vitro High-Throughput Screening Assays for the Estrogen Receptor. , 2015, Toxicological sciences : an official journal of the Society of Toxicology.

[6]  T. Hartung.  Toxicology for the twenty-first century , 2009, Nature.

[7]  J. Ashby,et al.  Uterotrophic activity of bisphenol A in the immature mouse. , 2000, Regulatory toxicology and pharmacology : RTP.

[8]  C. Austin,et al.  Improving the Human Hazard Characterization of Chemicals: A Tox21 Update , 2013, Environmental health perspectives.

[9]  Barbara A Wetmore,et al.  Quantitative in vitro-to-in vivo extrapolation in a high-throughput environment. , 2015, Toxicology.

[10]  J. Ashby,et al.  Sensitivity of the immature rat uterotrophic assay to mixtures of estrogens. , 2004, Environmental health perspectives.

[11]  In Young Kim,et al.  Validation Study of OECD Rodent Uterotrophic Assay for The Assessment of Estrogenic Activity in Sprague-Dawley Immature Female Rats , 2005, Journal of toxicology and environmental health. Part A.

[12]  David M. Reif,et al.  Update on EPA's ToxCast program: providing high throughput decision support tools for chemical risk management. , 2012, Chemical research in toxicology.

[13]  W. Casey,et al.  Application of Reverse Dosimetry to Compare In Vitro and In Vivo Estrogen Receptor Activity , 2015 .

[14]  Robert J Kavlock,et al.  Integration of dosimetry, exposure, and high-throughput screening data in chemical toxicity assessment. , 2012, Toxicological sciences : an official journal of the Society of Toxicology.

[15]  Lei Xu,et al.  The EDKB: an established knowledge base for endocrine disrupting chemicals , 2010, BMC Bioinformatics.

[16]  J. Ashby,et al.  Gene expression changes in the immature rat uterus: effects of uterotrophic and sub-uterotrophic doses of bisphenol A. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.

[17]  David M. Reif,et al.  In Vitro Screening of Environmental Chemicals for Targeted Testing Prioritization: The ToxCast Project , 2009, Environmental health perspectives.

[18]  William Owens,et al.  The OECD program to validate the rat uterotrophic bioassay. Phase 2: dose-response studies. , 2003, Environmental health perspectives.

[19]  J. Larsen,et al.  Lack of oestrogenic effects of food preservatives (parabens) in uterotrophic assays. , 2000, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[20]  D. Dix,et al.  The ToxCast program for prioritizing toxicity testing of environmental chemicals. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[21]  J. Kanno,et al.  Ovariectomized mouse uterotrophic assay of 36 chemicals. , 2012, The Journal of toxicological sciences.

[22]  J. Ashby,et al.  Comparison of the developmental and reproductive toxicity of diethylstilbestrol administered to rats in utero, lactationally, preweaning, or postweaning. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[23]  Ann Richard,et al.  ACToR--Aggregated Computational Toxicology Resource. , 2008, Toxicology and applied pharmacology.

[24]  William Owens,et al.  The OECD program to validate the rat uterotrophic bioassay: an overview. , 2003, Environmental health perspectives.

[25]  J Ashby,et al.  The OECD program to validate the rat uterotrophic bioassay to screen compounds for in vivo estrogenic responses: phase 1. , 2001, Environmental health perspectives.

[26]  S. Kang,et al.  Stimulation of calbindin-D9k mRNA expression in the rat uterus by octyl-phenol, nonylphenol and bisphenol , 2002, Molecular and Cellular Endocrinology.

[27]  P. Chambon,et al.  Activation function 2 (AF2) of estrogen receptor-α is required for the atheroprotective action of estradiol but not to accelerate endothelial healing , 2011, Proceedings of the National Academy of Sciences.